Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cousins Properties Announces $250 Million Share Repurchase Program
-
Storyteller Overland Debuts the TOUR MODE Adventure Van -- An All-Access Pass to Your Best Life on the Road
-
DryRun Security Appoints Andrew Peterson to Board of Directors
-
KnowBe4 Report Reveals U.S. Public Sector Faces Unrelenting Cyber Threats
-
Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia
-
Revvity to Present at Upcoming Investor Conferences
-
94% of Developers Would Switch Vendors as Agentic AI Triggers Infrastructure Race
-
Pitney Bowes Appoints Accomplished Financial Services Leader Steve Fischer as President of The Pitney Bowes Bank
-
Iowa State center Audi Crooks leads the 2025-26 Allstate NACDA Winter Good Works Team, recognizing 20 student-athletes giving back to their communities
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Redfin Reports U.S. Home Prices Crept Up 0.3% in January
-
Applebee’s Launches NEW Still Together Sips Featuring Still G.I.N. By Dre and Snoop
-
Esri and Pix4D Launch Real-Time Terrestrial Mapping Workflow
-
New Teleport Research Reveals AI Security Crisis in the Enterprise: Over-Privileged AI Systems Drive 4.5x Higher Incident Rates
-
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
-
Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
-
Valaris Reschedules Fourth Quarter 2025 Earnings Release and Cancels Conference Call
-
TPG Peppertree and Telecom Infrastructure Industry Veteran Bernard Borghei Announce Billion Dollar Investment Partnership
-
Cloudflare and Mastercard Partner to Extend Comprehensive Cyber Defense Across Critical Infrastructure and Small Businesses
-
Horace Mann Launches Exclusive Program that Offers Fitness, Financial Wellness, and Exclusive Discounts to Support Educators Nationwide
-
National Lacrosse League Team Names Toshiba Exclusive Technology Provider
-
Superior HealthPlan Publishes 2025 Community Investment Report
-
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
-
Spirent Introduces First Domain-Trained Agentic AI Solution for Network Testing and Assurance
-
Leixir Dental Lab Group and Bite-Finder AG Partner to Advance Digital Precision
-
Seanergy Maritime Reports Strong Fourth Quarter and Full-Year 2025 Results
-
Spazious & FirstView Join Visiting Media to Build a Global Platform for Immersive Hospitality Sales
-
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
-
Mepolizumab May Be Protective Against Small Airway Disfunction Exacerbation Risks in Children
-
SEALSQ Announces FY 2025 Key Preliminary / Unaudited Financials Metrics: Reports 66% Year Over Year Revenue Growth to $18 Million
-
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
-
Alan Launches Alan Clinic in Canada: Bringing Mental Health Care Directly Into the Insurance App
-
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
-
Mutuum Finance (MUTM) Reports Accelerated Roadmap Execution with V1 Protocol Activated
-
EagleNXT MicaSense™ RedEdge-P Triple Sensor Array Drives Advanced Climate Research
-
LGI Homes, Inc. Reports Fourth Quarter and Full Year 2025 Results and Issues Guidance for 2026
-
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform
-
IP Strategy Issues Statement on Aria’s Frontline K-Pop Release with RESCENE, Highlighting AI-Native Music Ownership on Story
-
Westervelt Ecological Services Welcomes Corblu Ecology Group, Strengthening a Shared Commitment to Long-Term Conservation
-
ARKO Corp. and ARKO Petroleum Corp. Announce Closing of ARKO Petroleum Corp.’s Initial Public Offering
-
DIRTT Enters into Support Agreement and Appoints New Director
-
Graham Corporation Announces Appointment of William Zmyndak as Deputy General Manager of Graham Manufacturing
-
Refinity Validates Breakthrough Waste Conversion Technology, Advancing Toward Commercial Demonstration
-
Kite Realty Group Reports Fourth Quarter and Full Year 2025 Operating Results and Provides 2026 Guidance
-
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
-
Vongvanith Named Kinetic’s First Chief Customer Officer; Brings Customer Voice to Senior Leadership
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Extendicare Announces February 2026 Dividend of C$0.042 per Share
